Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last --
Change Today 0.00 / 0.00%
Volume 0.0
All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Arlene M. Morris

Chief Executive Officer, President and Director, Syndax Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 128 board members in 5 different organizations across 7 different industries.

See Board Relationships
As of Fiscal Year 2013


Ms. Arlene M. Morris has been the Chief Executive Officer of Syndax Pharmaceuticals, Inc. since March 2012 and has been its President since September 2013. Ms. Morris served as a Consultant of Affymax Inc. from February 1, 2011 to September 30, 2011. She served as the Chief Executive Officer of Affymax, Inc. from June 2003 to February 1, 2011 and its President from June 2003 to April 2010. Ms. Morris served as the Chief Executive Officer and President of Clearview Projects ...

Read Full Background

Corporate Headquarters*

400 Totten Pond Road
Waltham, Massachusetts 02451

United States

Phone: 781-419-1400
Fax: 781-419-1420

Board Members Memberships*

Former Chief Executive Officer
Former Director, Chairman of Compensation Committee and Member of Audit Committee
Former Director and Member of Compensation Committee
Chief Executive Officer, President and Director


Carlow College
Unknown/Other Education
Western New England College

Other Affiliations*

Annual Compensation*

Total Annual Compensation$587,471

Stock Options*

All Other Compensation$22,692
Exercisable Options327,959
Total Number of Options327,959

Total Compensation*

Total Annual Cash Compensation$610,163
Total Short Term Compensation$587,471
Other Long Term Compensation$22,692
Total Calculated Compensation$2,467,358
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SNDX:US $0.00 USD 0.00


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SYNDAX PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at